Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 49.84 Delayed Data As of 3:59pm ET |  +2.56 / +5.41%Today’s Change | 37.59 Today|||52-Week Range 102.00 | -33.35% Year-to-Date |
Latest ENTA News | Press Releases
| Enanta Pharmaceuticals (ENTA) Stock Jumps 10.1%: Will It Continue to Soar? Jun 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 47.28 |
| Today’s open | 47.25 |
| Day’s range | 47.25 - 49.96 |
| Volume | 10,166 |
| Average volume (3 months) | 262,578 |
| Market cap | $932.5M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -115.92% |
| Earnings growth (this year) | -45.44% |
| Earnings growth (next 5 years) | -83.30% |
| Revenue growth (last year) | -20.74% |
| P/E ratio | NM |
| Price/Sales | 11.80 |
| Price/Book | 2.28 |
Competitors
| ---- | ||
| AMRXAmneal Pharmaceutica... | +0.18 | +5.66% |
| MNKDMannKind Corp | +0.15 | +4.07% |
| CRNXCrinetics Pharmaceut... | +0.22 | +1.18% |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$1.38 |
| Annual revenue (last year) | $97.1M |
| Annual profit (last year) | -$79.0M |
| Net profit margin | -81.38% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
